These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. Kim SK, Kim SH, Lee WJ, Kim H, Seo JW, Choi D, Lim HK, Lee SJ, Lim JH. AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056 [Abstract] [Full Text] [Related]
3. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. Ba-Ssalamah A, Schima W, Schmook MT, Linnau KF, Schibany N, Helbich T, Reimer P, Laengle F, Wrba F, Kurtaran A, Ryan M, Mann FA. AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034 [Abstract] [Full Text] [Related]
4. Inflammatory pseudotumor of the liver: MRI with mangafodipir trisodium. Materne R, Van Beers BE, Gigot JF, Horsmans Y, Lacrosse M, Pringot J. J Comput Assist Tomogr; 1998 Dec; 22(1):82-4. PubMed ID: 9448766 [Abstract] [Full Text] [Related]
11. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Wang C. Acta Radiol Suppl; 1998 Mar; 415():1-31. PubMed ID: 9571956 [Abstract] [Full Text] [Related]